Erlocip Tablet

ApplicationErlocip Tablet is consumed for curing non-small cell lung cancer. Erlocip Tablet is consumed in blend with gemcitabine for curing pancreatic cancer that has spread to nearby tissues or to other parts of the body.
Side EffectsBreathing, swelling of the tongue, lips, hives or face, increased coughing, chest pain, fever, severe or persistent nausea, loss of appetite, vomiting, eye pain or irritation, diarrhoea, dryness, skin rash, itching, weakness, acne, peeling, blistering
Types of DiseasesPancreatic Cancer, Non-small Lung Cancer
Drug NameErlotinib
Company nameCipla
Supply TypeManufacturer, Exporter, Supplier, Retailer, Trader
Preferred Buyer Location All over the world